University College London: Novel Treatment for Motor Neuron Disease to Be Trialed in Humans
July 27, 2026
July 27, 2026
LONDON, England, July 27 -- The University College London posted the following news:
* * *
Novel treatment for motor neurone disease to be trialled in humans
A pioneering experimental treatment for motor neurone disease (MND), developed by UCL spinout Trace Neuroscience, will be trialled in humans as part of a new international clinical programme.
The biopharma company, co-founded by Professor Pietro Fratta (UCL Queen Square Institute of Neurol . . .
* * *
Novel treatment for motor neurone disease to be trialled in humans
A pioneering experimental treatment for motor neurone disease (MND), developed by UCL spinout Trace Neuroscience, will be trialled in humans as part of a new international clinical programme.
The biopharma company, co-founded by Professor Pietro Fratta (UCL Queen Square Institute of Neurol . . .